SCHEMBL21034937

SCHEMBL21034937

COC(=O)[C@@H]1C[C@H](Oc2ccc(Cl)cc2)CCN1S(=O)(=O)c1ccc2cc(OC3CCCC3)ccc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 3/20 0.47
ITGA4 P13612 3/20 0.47
HTR1A P08908 2/20 0.46
HTR7 P34969 2/20 0.46
HTR5A P47898 2/20 0.46
HTR1D P28221 1/20 0.46
HTR1B P28222 1/20 0.46
HTR2A P28223 1/20 0.46
HTR2C P28335 1/20 0.46
ADRA1A P35348 1/20 0.46
HTR2B P41595 1/20 0.46
HTR6 P50406 1/20 0.46
HTR4 Q13639 1/20 0.46
HCRTR1 O43613 6/20 0.44
HCRTR2 O43614 6/20 0.44
KCNQ1 P51787 1/20 0.43
MMP1 P03956 2/20 0.43
ADAM17 P78536 1/20 0.43
CASP3 P42574 1/20 0.42
EPHX2 P34913 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21034994 1.00 ITGB1 (0.47) ITGB1ITGA4HTR1AHTR7HTR5A
SCHEMBL21034999 1.00 ITGB1 (0.47) ITGB1ITGA4HTR1AHTR7HTR5A
SCHEMBL21035678 0.97 ITGB1 (0.45) ITGB1ITGA4HTR1AHTR7HTR5A
SCHEMBL21035009 0.97 ITGB1 (0.45) ITGB1ITGA4HTR1AHTR7HTR5A
SCHEMBL21035398 0.92 HTR1A (0.42) ITGB1ITGA4HTR1AHTR7HTR5A
SCHEMBL21035317 0.92 HTR1A (0.42) ITGB1ITGA4HTR1AHTR7HTR5A
SCHEMBL21035666 0.90 ITGB1 (0.49) ITGB1ITGA4HTR1AHTR7HTR5A
SCHEMBL21034997 0.87 ITGB1 (0.47) ITGB1ITGA4HTR1AHTR7HTR5A
SCHEMBL21035002 0.87 MMP1 (0.47) HCRTR1HCRTR2MMP1ADAM17CASP3
SCHEMBL21035010 0.87 MMP1 (0.47) HCRTR1HCRTR2MMP1ADAM17CASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019104011-A1 CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2019-05-31 WO disclosed